SS-31 is a potent therapeutic peptide that treats mitochondrial disorders and reverses mitochondrial damage, mitigates the risk of oxidative damage by reducing oxidative stress manifested in mitochondria.
SS-31 is also known to improve neurodegenerative diseases as well as cardiovascular disease.
Energy & Fatigue Support
The most commonly reported clinical outcome of SS-31 therapy is improved energy and reduced fatigue. The mechanism is direct: when mitochondria produce ATP more efficiently, the cells that depend on that ATP have more energy available for all their functions. This manifests subjectively as improved stamina, reduced fatigability during both physical and mental tasks, and a general sense of increased vitality.
Patients who report the most dramatic energy improvements from SS-31 are typically those with pre-existing mitochondrial dysfunction — whether from aging, chronic illness, or metabolic stress. For these patients, the gap between current and optimal mitochondrial function is largest, and SS-31 bridges more of that gap. For younger, healthier patients, the energy improvements tend to be subtler but still meaningful as part of a comprehensive longevity protocol.
• Reduced chronic fatigue: directly addresses the mitochondrial component of energy-related fatigue
• Improved physical stamina: more ATP available to muscle tissue for sustained exertion
• Better mental energy: the brain’s high energy demands are better met by optimized mitochondrial function
• Faster recovery from exertion: cellular energy recovery after physical or cognitive demands improves
Exercise Recovery & Athletic Performance
Skeletal muscle is the most mitochondria-dense tissue in the body by volume. The performance, recovery, and adaptation of skeletal muscle are all fundamentally mitochondrial processes. SS-31’s effects on muscle tissue make it particularly relevant for active patients and athletes:
• Improved lactate clearance: mitochondrial efficiency affects how quickly lactate accumulates during high-intensity exercise and how quickly it is cleared during recovery
• Reduced exercise-induced oxidative stress: the oxidative stress generated by intense exercise is substantially mitochondrial in origin. SS-31’s ROS reduction at the mitochondrial level reduces exercise-induced oxidative damage to muscle tissue
• Faster muscle recovery: the cellular repair processes that rebuild muscle tissue post-exercise require significant ATP. More efficient mitochondrial ATP production supports faster and more complete muscle recovery
• Sustained performance over time: chronic oxidative mitochondrial stress is a primary driver of the training-induced performance decline that occurs without adequate recovery. SS-31 addresses the cellular mechanism underlying this pattern
Longevity & Healthy Aging
Mitochondrial decline is considered one of the nine hallmarks of cellular aging identified in the landmark 2013 paper by Lopez-Otin et al. — a classification that has become foundational in longevity medicine. The recognition that mitochondrial dysfunction is central to the aging process rather than a symptom of it has made mitochondria-targeting compounds like SS-31 core elements of advanced longevity protocols.
SS-31’s longevity relevance is not limited to energy — it addresses the oxidative stress component of cellular aging at its source. Chronic mitochondrial ROS generation contributes to DNA damage, protein carbonylation, lipid peroxidation, and the inflammation patterns that accelerate aging across all tissue types. By reducing ROS at the point of generation, SS-31 provides systemic anti-aging benefit.
• Addresses a central hallmark of aging: mitochondrial dysfunction is not peripheral to aging — it is mechanistically central to it
• Systemic ROS reduction: reducing oxidative stress at its source provides cellular protection across all tissues simultaneously
• Cellular energy preservation: maintaining energy production capacity as cells age supports all other cellular functions
Brain & Cognitive Support
The brain is the most energy-intensive organ in the body — consuming approximately 20% of the body’s total energy output despite comprising only 2% of its mass. This extraordinary energy demand makes brain function exquisitely sensitive to mitochondrial health. When mitochondrial efficiency declines in neural tissue, cognitive function is among the first things affected.
Patients who use SS-31 for longevity or energy often report ancillary improvements in cognitive clarity, mental stamina, and the ability to sustain focused attention. These are consistent with the mitochondrial energy support mechanism — better ATP availability in neural tissue directly translates to better cognitive performance.
• Mental clarity improvement: cognitive “fog” often reflects insufficient neural energy availability. SS-31 addresses the cellular energy component.
• Sustained cognitive endurance: the ability to maintain focus and mental performance over extended periods reflects mitochondrial energy sufficiency in neural tissue
• Neuroprotection through ROS reduction: oxidative stress is a significant driver of neuronal damage in aging. SS-31’s mitochondrial ROS reduction provides neuroprotective benefits.
Cardiovascular & Cellular Health
Cardiac muscle cells are among the most mitochondria-dependent in the body — they operate continuously and require constant high-level ATP production. SS-31’s clinical research program was built substantially around cardiac applications, with studies demonstrating improved cardiac function in ischemia-reperfusion injury models and heart failure research contexts. While these are research rather than approved treatment contexts, they reflect the mechanism’s particular relevance to cardiac tissue health.
• Cardiac mitochondrial support: heart muscle cells are among the highest consumers of mitochondrial energy in the body
• Endothelial function: vascular endothelial cells are also highly mitochondria-dependent; SS-31 may support vascular tissue health
• Broad cellular protection: SS-31’s ROS reduction benefits extend to every cell type, with the most pronounced effects in the most mitochondria-dependent tissues